The antidepressant effect and safety of non-intranasal esketamine: A systematic review
Journal of Psychopharmacology May 1, 2022 Sanne Y. Smith-Apeldoorn, Maurice Vischjager, Jolien K. E. Veraart et al. 26 citations
BACKGROUND: The introduction of esketamine into the field of psychiatry comes on the heels of excitement from studies on racemic ketamine. While the intranasal route has been the most studied to date, other modes of administration of esketamine may also be of interest in the management of depression. AIMS: To systematically review the literature on non-intranasal esketamine for depression in...